PARIS--(BUSINESS WIRE)--Elixir Medical, a developer of transformative technologies to treat cardiovascular and peripheral disease, today announced that the PINNACLE I study evaluating the safety and ...
MILPITAS, Calif.--(BUSINESS WIRE)--Elixir Medical, a developer of disruptive cardiovascular technologies, announced submission to Japan’s Pharmaceutical and Medical Device Agency (PMDA) for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback